Skip to main content
. 2013 Apr 19;14(1):46. doi: 10.1186/1465-9921-14-46

Table 2.

Spirometry, quadriceps strength, functional exercise capacity, physical activity levels and blood serum parameters in patients during a respiratory exacerbation and in stable patients

 
 
Exacerbation
 
 
During exacerbation
Follow-up
Stable
 
(n = 19)
(n = 17)
(n = 10)
  Day 1 Day 14 Day 40  
Spirometry
FEV1 (L)
2.1 ± 0.9**,#
2.7 ± 1.1#
2.4 ± 1.0
2.8 ± 1.0
FEV1 (%pred)
55 ± 19**,##
69 ± 25#
61 ± 23
72 ± 22
FVC (L)
3.5 ± 1.0**
4.0 ± 1.2
3.7 ± 1.2
4.1 ± 0.8
Quadriceps strength and functional exercise capacity
Twqpot (N)
140 ± 42
140 ± 47
129 ± 35
158 ± 40
MVC (N)
378 ± 128
369 ± 119
353 ± 109
456 ± 157
6MWD (m)
/
694 ± 89§
698 ± 84§
786 ± 111
Physical activity
Daily steps (n)
4654 ± 2929#,§
7174 ± 4423
7414 ± 2810
 
Time > 4.8 METs (min)
6 [2-17] #
14 [4–40]
11 [6–35]
 
Hematological parameters, testosterone and systemic inflammation
Hemoglobin (g/dL)
13.9 ± 1.5
13.7 ± 1.6
13.8 ± 1.4
14.8 ± 1.2
Blood platelets (x109/L)
314 ± 109*
287 ± 104
339 ± 87
250 ± 63
Testosterone (in men) (ng/dL)
249 [148–281]
354 [251–442]
256 [209–363]
/
WBC count (x109/L)
12.6 ± 4.3**,#,§
8.6 ± 3.1
9.9 ± 2.3§
7.4 ± 2.2
Neutrophil count (x109/L)
8.6 ± 3.0**
5.2 ± 2.4
7.1 ± 2.4§
4.7 ± 1.8
CRP (mg/L) 13 [8–48]** 3 [0–5] 9 [7-18] § 2 [0–7]

Data are presented as mean ± standard deviation or median [interquartile range].

Data in the stable group are data from the first assessment, except for physical activity measurements, which are the mean values over a 14-day assessment period.FEV1 = forced expiratory volume in one second; %pred = percentage of the predicted value; FVC = forced vital capacity; Twqpot = potentiated quadriceps twitch force; MVC = maximal voluntary contraction force of the quadriceps, 6MWD = six-minute walking distance, MET = metabolic equivalent, WBC = white blood cells, CRP = C-reactive protein. *p < 0.05 vs. day 14 **, p < 0.001 vs. day 14, # p < 0.05 vs. day 40, ## p < 0.001 vs. day 40, §p < 0.05 vs. stable.